BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35283377)

  • 1. Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis.
    Nishikawa T; Kunimasa K; Ohta-Ogo K; Ikeda Y; Yasui T; Shioyama W; Oka T; Honma K; Hatakeyama K; Kumagai T; Fujita M
    Intern Med; 2022 Jul; 61(14):2161-2165. PubMed ID: 35283377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
    Prevel R; Colin G; Calès V; Renault PA; Mazieres J
    Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
    Saad R; Ghaddar A; Zeenny RM
    J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis, myositis and myocarditis: a fatal triad of immune-related adverse effect of immune checkpoint inhibitor treatment.
    Soman B; Dias MC; Rizvi SAJ; Kardos A
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
    Coustal C; Vanoverschelde J; Quantin X; Lesage C; Michot JM; Lappara A; Ederhy S; Assenat E; Faure M; Issa N; Lambotte O; Puyade M; Dereure O; Tosi D; Rullier P; Serre I; Larcher R; Klouche K; Chanques G; Vernhet-Kovacsik H; Faillie JL; Agullo A; Roubille F; Guilpain P; Maria ATJ
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
    Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
    J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sick sinus syndrome associated with anti-programmed cell death-1.
    Hsu CY; Su YW; Chen SC
    J Immunother Cancer; 2018 Jul; 6(1):72. PubMed ID: 30012209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sick Sinus Syndrome: More Than a Needle-in-a-haystack Manifestation of Immune Checkpoint Inhibitor-associated Myocarditis.
    Kadowaki H; Akazawa H
    Intern Med; 2022 Jul; 61(14):2101-2102. PubMed ID: 35283389
    [No Abstract]   [Full Text] [Related]  

  • 12. Routine assessment of cardiotoxicity in patients undergoing long-term immune checkpoint inhibitor therapy.
    Tamura Y; Tamura Y; Yamada K; Taniguchi H; Iwasawa J; Yada H; Kawamura A
    Heart Vessels; 2022 Nov; 37(11):1859-1865. PubMed ID: 35633369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer.
    Hu Y; Liu C; Jin S; Yi Z; Wang C; Pan X; Huang H
    BMC Pulm Med; 2023 Apr; 23(1):119. PubMed ID: 37060029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy.
    Murakata Y; Tajiri K
    Intern Med; 2022 Jul; 61(14):2099-2100. PubMed ID: 35283387
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians.
    Raschi E; Rossi S; De Giglio A; Fusaroli M; Burgazzi F; Rinaldi R; Potena L
    Drug Saf; 2023 Sep; 46(9):819-833. PubMed ID: 37341925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
    Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
    J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis.
    Ederhy S; Fenioux C; Cholet C; Rouvier P; Redheuil A; Cohen A; Salem JE
    Can J Cardiol; 2021 Oct; 37(10):1654-1656. PubMed ID: 33373722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Glucocorticoid Effect Observation in a Ureteral Urothelial Cancer Patient With ICI-Associated Myocarditis and Multiple Organ Injuries.
    Hu X; Wei Y; Shuai X
    Front Immunol; 2021; 12():799077. PubMed ID: 34975911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.